| • |
Efficacy of the CYPHER SelectTM Sirolimus-Eluting
Coronary Stent Implantation for Coronary Artery Stenosis |
| • |
Randomized Comparison Study of CypherTM Stent versus
Brachytherpy for Treatment of Diffuse In-Stent Restenosis |
| • |
The effect of sirolimus-eluting stent for very long
coronary lesions |
| • |
The effect of paclitaxel-eluting stent for very long
coronary lesions |
| • |
Randomized Comparison of Triple versus Dual antiplatelet
therapy after Drug-Eluting Stent Implantation; Will there be a synergy
of DES and cilostazol in restenosis reduction |
| • |
Effects of Rosiglitazone on Neointimal Hyperplasia
after Coronary Stent Implantation in Patients with Diabetes Mellitus:
A Serial Intravascular Ultrasound Study |
| • |
Comparison of Co-Cr alloy ArthosPico stent with sirolimus-eluting
stent for simple de novo coronary lesions |
| • |
Efficacy of Sirolimus-Eluting Stent Implantation for
Ostial Left Anterior Descending Artery Stenosis |
| • |
Comparison of Early and Mid-term Outcomes after Sirolimus-Eluting
Stent implantation Versus Coronary Artery Bypass Grafting in Patients
with Multivessel Coronary Artery Disease. |
| • |
percutaneous treatment of LONG native coronary lesions
with Drug-Eluting Stent: Cypher versus Taxus : LONG-DES |
| • |
Identification Of Patients At Low Risk OF 6-month Instent
Restenosis Of Bare Metal Stenting In the Real World |
| • |
Glycosylated Hemoglobin Level as a Predictor of Restenosis
after Drug-Eluting Stent Implantation in Diabetes Mellitus Patients |
| • |
Tissue Plasminogen Activator on Admission is an Important
Predictor for 30-day Mortality in Patients with Acute Myocardial Infarction
Undergoing Primary Angioplasty |
| • |
Serial Intravascular Ultrasound Findings in Patients
with Ruptured Coronary Plaques: Evidence of Both Plaque Stabilization
and Lesion Progression |
| • |
Evaluation of neo-endothelization at the stent overlapping
segment after kissing stenting with sirolimis-eluting stent |
| • |
Effects of atorvastatin versus rosuvastatin therapy
on coronary atherosclerotic plaque: a prospective randomized comparison
trial with intravascular ultrasound |
| • |
Validation of New Drug-Eluting Stent in a Porcine Coronary
Artery Model of Restenosis |
| • |
Multicenter study for evaluating the procedural efficacy
and initial safety of the TAXUS LiberteTM paclitaxeleluting stent
in coronary lesions |
| • |
Valsartan for Suppression of Plaque volume and Restenosis
After paclitaxel-Eluting Stent |
| • |
EuroSCORE as a Predictor of Death and Myocardial Infarction
after Unprotected Left Main Coronary Stenting |
| • |
Repeated Sirolimus-Eluting Stent Implantation for the
Treatment of Drug-Eluting Stent Restenosis: Comparison with Conventional
Therapies |
| • |
tritace PEP Study in Metabolic Syndrome |
| • |
Comparison of the Efficacy of Zotarolimus(ABT 578)-
Eluting Stent versus Sirolimus-Eluting Stent versus Paclitaxel-Eluting
Stent for Coronary Lesions: The Prospective, Randomized, and Multi-center
Trial |
| • |
Effects of Triple Antiplatelet Therapy on Platelet
Function in Patients with Diabetes Mellitus Undergoing Percutaneous
Coronary Stenting |
| • |
To Evaluate the 'Real World' Clinical Performance of
the Medtronic EndeavorTM ABT-578 Eluting Coronary Stent System : A
Prospective, Multicenter Registry (E-Five Registry) |
| • |
Premier of Randomized Comparison of Sirolimus- Eluting
Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected
Left Main Coronary Artery Stenosis: PhaseIII : Multicenter trial:
PRECOMBAT Trial |
| • |
A Multicenter, Randomized, Double-Blind, Parallel Arm,
6-week Study to Evaluate the Efficacy and Safety of Ezetimibe/Simvastatin
Versus Atorvastatin in Patients with Metabolic Syndrome and hypercholesterolemia
at High Risk for Coronary Heart Disease |
| • |
Impact of cilostazol on neointimal hyperplasia after
ABT578-eluting stent implantation in patients with long coronary lesions:
prospective, double blind, randomized, multicenter trial |
| • |
Focal Type In-stent Restenosis after Drug-Eluting Stent
Implantation Treated by CUtting Balloon Angioplasty versus Sirolimus-Eluting
Stent: |
| • |
Revascularization Treatment for Unprotected Left Main
Coronary Artery Stenosis in Korea: Comparison of Percutaneous Coronary
Intervention versus Coronary Artery Bypass Surgery "Left Main
Registry in Korea" |
| • |
Evaluation of the Long-term Safety After Zotarolimus-
Eluting Stent, Sirolimus-Eluting Stent, or PacliTaxel- Eluting Stent
Implantation for Coronary Lesions-Late Coronary Arterial Thrombotic
Events: The ZEST-LATE trial |
| • |
Comparison between Drug-Eluting Stents for the Treatment
of the Diffuse Type In-Stent Restenosis after Drug-Eluting Stents
Implantation: Sirolimus-Eluting vs. Paclitaxel-Eluting Stents (DES-ISR
Trial) |
| • |
The e-SELECT Registry A MultiCenter Post Market Surveillance |
| • |
Preventive Strategies of REnal Insufficiency in Patients
with Diabetes Undergoing InterVENTion or Arteriography: PREVENT Trial |
| • |
Correlation of Clopidogrel Therapy Discontinuation
in REAL-world Patients Treated with Drug-Eluting Stent Implantation
and Late Coronary Arterial Thrombotic Events: REAL-LATE Trial |
| • |
Patient Related OuTcomes with Endeavor versus Cypher
stenting Trial Prospective, Multicenter, Randomized, Two-arm, Open-label
Trial |
| • |
Comparison of the Efficacy and Safety of Paclitaxel-
Coated, Bio-compatible Polymer, Cobalt-Chronium ThIn Strut Stent (PICOELITE)
versus Paclitaxel-Eluting Stent (TAXUS) in Patients with Coronary
Artery Disease |
| • |
A Randomized Comparison of Percutaneous CLip-based
Vascular Occluder (Star-Close) versus Bio-absorble Hemostatic Device
(Angio-SEal) for Femoral Artery Hemostasis after Percutaneous Coronary
Intervention: The CLOSE Trial |
| • |
Randomized Comparison of Triple versus Dual Antiplatelet
Therapy in Patients undergoing Primary Stenting in the setting of
ST-elevation Acute Myocardial Infarction |
| • |
Optimal stenting strategy for true bifurcation lesion |
| • |
Choice of optimal stRategy fOr bifurcation leSions
with normal Side branch |
| • |
Comparison of the Efficacy and Safety of PaclItaxel-
Eluting CoroflexTM Please Stent versus Paclitaxel- Eluting Stent in
Patients with Coronary Artery Disease |
